Alzheimer’s disease modeling and drug screening through hiPSC 3D bioprinting
Stefano Sorrentino, Stefan Wendt, Wenji Cai, Christopher Lee, Declan Brennan, Xiujuan Wu, Haakon B Nygaard · 2025
Read Alzheimer’s disease modeling and drug screening through hiPSC 3D bioprinting by Stefano Sorrentino, Stefan Wendt, Wenji Cai, Christopher Lee, Declan Brennan, Xiujuan Wu, Haakon B Nygaard (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710323.txt.
Description
Brain organoids grown from stem cells can model Alzheimer's disease, but they form on their own and so vary from batch to batch. Stefano Sorrentino and co-authors built a more controlled model in 2025 by 3D bioprinting, laying down living cells and materials in a wood-pile pattern that mimics the cortex. Their ink carried precursor cells that can become neurons and support cells.
The printed cells stayed alive, grew, and matured into working cortical neurons and astrocytes. When a synthetic amyloid protein was added, immune cells grown from the same stem cell source moved into the structure and ate the deposits. The authors say the model could reveal the earliest steps of the disease and serve as a test bed for drugs, without animal models.
Catalog record
| CREATOR | Stefano Sorrentino, Stefan Wendt, Wenji Cai, Christopher Lee, Declan Brennan, Xiujuan Wu, Haakon B Nygaard |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |